Spyre Therapeutics Income Statement (2015-2026) | SYRE

Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
2.63M2.63M2.64M3.29M3.77M3.37M3.77M3.24M4.05M6.90M36.63M50.78M51.40M47.03M60.28M60.37M60.47M64.06M78.84M88.06M
Revenue & cost
Revenue (Quarter)
12.00M3.64M1.36M0.62M0.17M0.17M0.20M0.69M
Operating items
Research & Development (Quarter)
14.85M16.78M16.98M15.37M11.98M14.25M13.78M17.39M24.66M33.68M34.93M32.64M44.74M50.48M41.62M40.15M45.25M44.64M60.41M65.50M
Selling, General & Administrative (Quarter)
6.84M7.30M8.82M7.67M6.95M5.08M5.23M12.06M8.58M14.07M12.85M11.51M10.65M10.77M11.94M11.79M11.64M12.53M15.23M16.14M
Other Operating Expenses (Quarter)
130.49M14.61M1.84M10.00M30.00M40.00M
Operating Expenses (Quarter)
21.69M24.09M25.80M23.05M18.93M19.33M19.00M159.93M18.34M45.91M47.77M44.15M55.39M61.25M53.57M41.94M56.89M57.17M45.64M41.64M
Operating Income (Quarter)
-20.29M-20.44M-24.44M-22.42M-18.75M-19.16M-18.81M-159.25M-18.34M-45.91M-47.77M-44.15M-55.39M-61.25M-53.57M-41.94M-56.89M-57.17M-45.64M-41.64M
EBIT (Quarter)
-20.29M-20.44M-24.44M-22.42M-18.75M-19.16M-18.81M-159.25M-18.34M-45.91M-47.77M-44.15M-55.39M-61.25M-53.57M-41.94M-56.89M-57.17M-45.64M-41.64M
Non-operating items
Interest & Investment Income (Quarter)
0.04M0.03M-0.12M-0.03M0.29M0.41M0.42M-0.00M1.25M4.13M-0.68M-0.19M5.18M5.78M6.49M-0.19M5.38M7.14M7.00M10.05M
Other Non Operating Income (Quarter)
-0.02M-0.01M-0.03M0.01M0.02M-0.03M-0.07M-0.01M2.34M-21.39M-0.48M-0.61M-18.80M-0.82M2.29M-0.66M40.33M-12.50M-30.36M-4.61M
Non Operating Income (Quarter)
0.01M0.02M0.01M0.11M0.31M0.38M0.35M-57.83M-21.77M-17.27M3.95M5.31M-13.62M4.96M8.78M5.22M45.70M-5.36M-23.36M5.44M
Net income details
EBT (Quarter)
-20.28M-20.42M-24.44M-22.31M-18.44M-18.78M-18.46M-217.07M-40.10M-63.18M-43.83M-38.84M-69.01M-56.30M-44.79M-36.72M-11.18M-62.53M-69.00M-36.20M
Tax Provisions (Quarter)
0.03M0.02M0.01M-0.21M0.04M-0.04M0.01M0.00M0.03M0.02M0.00M-0.01M
Profit After Tax (Quarter)
-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M-62.53M-69.00M-36.20M
Income from Continuing Operations (Quarter)
-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M-62.53M-69.00M-36.20M
Consolidated Net Income (Quarter)
-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M-62.53M-69.00M-36.20M
Income towards Parent Company (Quarter)
-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M-62.53M-69.00M-36.20M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M-62.53M-69.00M-36.20M
Additional items
EPS (Basic) (Quarter)
-7.72-7.77-9.26-6.79-4.84-5.58-4.89-56.79-9.34-9.16-1.20-0.86-1.36-1.20-0.74-0.61-0.19-0.98-0.88-0.43
EPS (Diluted) (Quarter)
-7.72-7.77-9.26-6.79-4.84-5.58-4.89-56.79-9.34-9.16-1.20-0.86-1.36-1.20-0.74-0.61-0.19-0.98-0.88-0.43
Shares Outstanding (Quarter)
2.63M2.63M2.64M3.29M3.77M3.37M3.77M3.82M4.29M6.90M36.51M45.32M50.89M47.03M60.27M60.33M60.41M64.06M78.55M84.73M
Shares Outstanding (Diluted) (Quarter)
2.63M2.63M2.64M3.29M3.77M3.37M3.77M3.82M4.29M6.90M36.51M45.32M50.89M47.03M60.27M60.33M60.41M64.06M78.55M84.73M
EBITDA (Quarter)
-20.29M-20.44M-24.44M-22.42M-18.75M-19.16M-18.81M-159.25M-18.34M-45.91M-47.77M-44.15M-55.39M-61.25M-53.57M-41.94M-56.89M-57.17M-45.64M-41.64M
Interest Expenses (Quarter)
0.02M0.33M0.16M0.18M0.12M0.19M0.12M125.49M0.45M0.67M0.02M162.93M0.16M0.15M0.04M0.12M1.06M2.49M
Tax Rate (Quarter)
-0.13-0.11-0.041.13-0.200.200.00-0.01-0.07-0.030.000.03